Results 191 to 200 of about 4,942 (259)

A Comprehensive Review of the Latest Approaches to Managing Hypercholesterolemia: A Comparative Analysis of Conventional and Novel Treatments: Part II. [PDF]

Pharmaceuticals (Basel)
Jianu N, Nițu ET, Merlan C, Nour A, Buda S, Suciu M, Luca SA, Sbârcea L, Andor M, Buda V.   +9 more
europepmc   +1 more source

Pleiotropic effects of inclisiran on arterial structural and functional parameters [PDF]

M Bellomare, G Toscani, Chiara Tognola, Atea Shkodra, Michela Algeri, S Fabbri, Roberto Pirola, I Garofani, F Politi, C Giannattasio, Alessandro Maloberti   +10 more
openalex   +1 more source

Protective Role of Lipid-Lowering Drugs in Breast Cancer: Effects on Cancer Incidence and Cardiotoxicity. [PDF]

Life (Basel)
Mauriello A, Correra A, Maratea AC, Fonderico C, Amata A, Cetoretta V, Russo V, D'Andrea A.   +7 more
europepmc   +1 more source

Inclisiran in individuals with diabetes or obesity: Post hoc pooled analyses of the ORION ‐9, ORION ‐10 and ORION ‐11 Phase 3 randomized trials [PDF]

Lawrence A. Leiter, Frederick J. Raal, Gregory G. Schwartz, Wolfgang Köenig, Kausik K. Ray, Ulf Landmesser, Jackie Han, Lorena Garcia Conde, R. Scott Wright   +8 more
openalex   +1 more source

siRNA Therapeutics for the Treatment of Hereditary Diseases and Other Conditions: A Review. [PDF]

Int J Mol Sci
Shevelev A, Pozdniakova N, Generalov E, Tarasova O.   +3 more
europepmc   +1 more source

Inclisiran in Atherosclerotic Cardiovascular Disease: A Systematic Review of Efficacy and Safety for Lipid Lowering and Risk Mitigation [PDF]

Darshan Kumar, Leena Pavitha
openalex   +1 more source

Evaluation of the Efficacy and Safety of Inclisiran in 30 Indian patients with Atherosclerotic Cardiovascular Disease – A Real-World Observational Study

Girish B Navasundi, Thuppil Venkatesh, Praneeth Suryadevara, M B   +3 more
openalex   +1 more source

Poland takes a lead in effective lipid disorders management healthcare programmes in Europe. [PDF]

Am J Prev Cardiol
Banach M, Mastalerz-Migas A, Wita K, Myśliwiec M.   +3 more
europepmc   +1 more source

Inclisiran in the treatment of high cardiovascular risk subjects: A real life experience [PDF]

Antonina Giammanco, D. Noto, Carola Maria Gagliardo, F Polizzi, Maria Laura Furnari, Federica Brucato, Carlo M. Barbagallo, Maurizio Averna, A.B. Cefalù   +8 more
openalex   +1 more source

Dyslipidemia Treatment in Patients with Acute Coronary Syndrome: Is It Time to Move to Combination Therapy? [PDF]

J Clin Med
Brie DM, Mornoș C, Adam O, Tîrziu A, Brie AD.   +4 more
europepmc   +1 more source